Skip to content

Praxis Precision Medicines

Praxis Precision Medicines is a fully integrated CNS precision neuroscience biopharmaceutical company developing therapies for central nervous system disorders.

Last updated September 16, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Praxis Precision Medicines is a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company. It translates insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. The company uses precision neuroscience to identify and target biologically defined mechanisms of disease, integrating insights from human biology, genetics, translational science, and patient experience. Its work supports a diversified portfolio across movement disorders and epilepsy, spanning both small molecule and antisense platforms.

History

Praxis Precision Medicines is a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company. It translates insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. The company applies precision neuroscience to identify and target biologically defined mechanisms of disease, integrating insights from human biology, genetics, translational science, and patient experience to guide therapeutic development. Its work supports a diversified portfolio across movement disorders and epilepsy, spanning both small molecule and antisense platforms.

Products and positioning

Fully integrated, leading CNS precision neuroscience biopharmaceutical company.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/praxis-precision-medicines-inc-united-states · Editorial policy · How profiles are compiled